11/11
10:22 am
dcth
Delcath Systems, Inc. (NASDAQ: DCTH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
Medium
Report
Delcath Systems, Inc. (NASDAQ: DCTH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
11/9
04:08 pm
dcth
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
High
Report
Delcath Systems Inc (DCTH) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... [Yahoo! Finance]
11/8
08:00 am
dcth
Delcath Systems Reports Third Quarter 2024 Results and Business Highlights
Low
Report
Delcath Systems Reports Third Quarter 2024 Results and Business Highlights
11/6
05:22 pm
dcth
Delcath Systems Q3 2024 Earnings Preview [Seeking Alpha]
Low
Report
Delcath Systems Q3 2024 Earnings Preview [Seeking Alpha]
11/1
04:01 pm
dcth
Delcath Systems to Participate in Upcoming Investor Conferences
Low
Report
Delcath Systems to Participate in Upcoming Investor Conferences
11/1
11:55 am
dcth
Delcath Systems, Inc. (DCTH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release [Yahoo! Finance]
Low
Report
Delcath Systems, Inc. (DCTH) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release [Yahoo! Finance]
10/25
08:30 am
dcth
Delcath Systems to Host Third Quarter 2024 Earnings Call
Low
Report
Delcath Systems to Host Third Quarter 2024 Earnings Call
10/25
02:07 am
dcth
Delcath Systems, Inc. (NASDAQ: DCTH) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Delcath Systems, Inc. (NASDAQ: DCTH) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
10/18
03:33 pm
dcth
Delcath Systems, Inc. (NASDAQ: DCTH) had its "buy" rating re-affirmed by analysts at Stephens.
Low
Report
Delcath Systems, Inc. (NASDAQ: DCTH) had its "buy" rating re-affirmed by analysts at Stephens.
10/18
10:34 am
dcth
Delcath Systems, Inc. (NASDAQ: DCTH) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $21.00 price target on the stock.
Medium
Report
Delcath Systems, Inc. (NASDAQ: DCTH) had its "buy" rating re-affirmed by analysts at Canaccord Genuity Group Inc.. They now have a $21.00 price target on the stock.
10/18
08:33 am
dcth
Delcath Systems, Inc. (NASDAQ: DCTH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
High
Report
Delcath Systems, Inc. (NASDAQ: DCTH) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $22.00 price target on the stock.
10/17
11:10 pm
dcth
Delcath Systems, Inc. (NASDAQ: DCTH) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Medium
Report
Delcath Systems, Inc. (NASDAQ: DCTH) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
10/17
10:48 am
dcth
Delcath Systems reports Q3 results [Seeking Alpha]
Low
Report
Delcath Systems reports Q3 results [Seeking Alpha]
10/17
08:30 am
dcth
Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results
Medium
Report
Delcath Systems Announces Preliminary Third Quarter 2024 Revenue Results
9/27
02:01 am
dcth
Delcath Systems, Inc. (NASDAQ: DCTH) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
Low
Report
Delcath Systems, Inc. (NASDAQ: DCTH) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
9/20
04:01 pm
dcth
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Low
Report
Delcath Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
9/19
02:34 am
dcth
Delcath Systems, Inc. (NASDAQ: DCTH) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Delcath Systems, Inc. (NASDAQ: DCTH) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
9/16
08:30 am
dcth
Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT™ in Metastatic Uveal Melanoma Subgroups
Low
Report
Delcath Systems Announces New Data Presented at ESMO 2024 Demonstrating Efficacy of HEPZATO KIT™ in Metastatic Uveal Melanoma Subgroups
9/9
11:02 pm
dcth
Delcath Systems, Inc. (NASDAQ: DCTH) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Low
Report
Delcath Systems, Inc. (NASDAQ: DCTH) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
9/2
11:09 am
dcth
Delcath Systems Stock Gains on Positive CHEMOSAT Melanoma Data [Yahoo! Finance]
Medium
Report
Delcath Systems Stock Gains on Positive CHEMOSAT Melanoma Data [Yahoo! Finance]
9/1
10:46 am
dcth
A US$84m Market Cap Boost Pleasing ToDelcath Systems Insiders [Yahoo! Finance]
Medium
Report
A US$84m Market Cap Boost Pleasing ToDelcath Systems Insiders [Yahoo! Finance]
8/28
04:01 pm
dcth
Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients
Low
Report
Delcath Systems, Inc. Announces Positive Results from Independent Study on Liver-Directed Therapy for Uveal Melanoma Patients
8/28
04:01 pm
dcth
Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
Low
Report
Delcath Systems to Participate at the H.C. Wainwright 26th Annual Global Investment Conference
8/28
07:01 am
dcth
Delcath's Hepzato Kit offers better disease control than immunotherapy [Yahoo! Finance]
Low
Report
Delcath's Hepzato Kit offers better disease control than immunotherapy [Yahoo! Finance]
8/27
08:45 am
dcth
Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients [Yahoo! Finance]
Medium
Report
Delcath Systems, Inc. Announces Positive Outcomes from Independent Study on Hepatic Perfusion for Uveal Melanoma Patients [Yahoo! Finance]